Genpharmasec Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 329838,
    "name": "Genpharmasec",
    "stock_name": "Genpharmasec",
    "full_name": "Genpharmasec Ltd",
    "name_url": "stocks-analysis/genpharmasec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1.34",
    "chg": 0.1,
    "chgp": "8.06%",
    "dir": 1,
    "prev_price": "1.24",
    "mcapval": "70.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531592,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE861N01036",
    "curr_date": "Feb 11",
    "curr_time": "",
    "bse_nse_vol": "35.86 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 11, 2026",
    "traded_date_str": "2026 02 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/genpharmasec-329838-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Genpharmasec Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-genpharmasec-ltd-latest-results-good-or-bad-3831458",
        "imagepath": "",
        "date": "2026-02-10 19:23:08",
        "description": "Genpharmasec Ltd's latest financial results for Q3 FY26 reveal significant operational challenges despite a remarkable surge in revenue. The company reported net sales of ₹39.83 crores, reflecting a substantial year-on-year growth of 369.69%. This marks the highest quarterly revenue in its recent history. However, this revenue growth has not translated into profitability, as the company posted a net loss of ₹0.83 crores, which is a stark contrast to the previous year's profit.\n\nThe operating margin has turned negative at -3.09%, a drastic decline from the positive margin of 8.37% achieved in the same quarter last year. This indicates a troubling disconnect between revenue generation and cost management. The operating loss before other income was recorded at ₹1.23 crores, highlighting severe operational inefficiencies. Additionally, employee costs surged significantly, outpacing revenue growth, which raises ..."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-3830538",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GenpharmasecLtd_mojoScore_3830538.png",
        "date": "2026-02-10 10:10:25",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 10 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Genpharmasec Q3 FY26: Losses Mount as Operating Margins Turn Negative Despite Revenue Surge",
        "link": "https://www.marketsmojo.com/news/result-analysis/genpharmasec-q3-fy26-losses-mount-as-operating-margins-turn-negative-despite-revenue-surge-3829161",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/Genpharmasec_quaterlyResult_3829161.png",
        "date": "2026-02-09 20:31:33",
        "description": "Genpharmasec Limited, a micro-cap trading and distribution company with a market capitalisation of ₹64.00 crores, has reported deeply concerning results for Q3 FY26 (October-December 2025), posting a net loss of ₹0.83 crores despite achieving its highest-ever quarterly revenue. The stock, currently trading at ₹1.16, has plummeted 48.21% over the past year and trades 51.67% below its 52-week high of ₹2.40, reflecting mounting investor concerns about the company's profitability trajectory."
      },
      {
        "title": "Are Genpharmasec Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-genpharmasec-ltd-latest-results-good-or-bad-3829035",
        "imagepath": "",
        "date": "2026-02-09 19:15:05",
        "description": "Genpharmasec Ltd's latest financial results reveal a complex picture of growth and operational challenges. In Q2 FY26, the company reported a net profit of ₹1.22 crore, which reflects a significant year-on-year increase of 269.70%. However, this positive trend is overshadowed by a sequential decline in net profit, which saw a dramatic drop of over 500% compared to the previous quarter. \n\nRevenue for the same quarter reached ₹12.04 crore, marking an impressive year-on-year growth of 131.54%. Yet, this growth was not consistent, as revenue declined by 14.06% from ₹14.01 crore in Q1 FY26. This volatility raises concerns about the sustainability of the company's revenue streams.\n\nThe operating margin, excluding other income, improved to 7.81% from 4.04% in the previous year, indicating some operational leverage. However, it remains below the 8.61% achieved in Q4 FY25, highlighting ongoing inconsistencies in ope..."
      },
      {
        "title": "Genpharmasec Ltd Falls to 52-Week Low Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpharmasec-ltd-falls-to-52-week-low-amidst-continued-underperformance-3814305",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GenpharmasecLtd_priceRelatedfactors_3814305.png",
        "date": "2026-02-01 10:45:02",
        "description": "Genpharmasec Ltd, a company operating in the Trading & Distributors sector, has reached a new 52-week low of Rs.0.98, marking a significant decline in its stock price. This fresh low reflects ongoing pressures on the stock, which has underperformed both its sector and the broader market over the past year."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-3811147",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GenpharmasecLtd_mojoScore_3811147.png",
        "date": "2026-01-30 10:10:35",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Genpharmasec Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpharmasec-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3798495",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GenpharmasecLtd_priceRelatedfactors_3798495.png",
        "date": "2026-01-21 11:17:27",
        "description": "Genpharmasec Ltd’s share price declined to a fresh 52-week low of Rs.1.06 today, marking a significant milestone in its ongoing downward trajectory. This new low reflects persistent pressures on the stock amid broader market weakness and company-specific factors."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-3794092",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GenpharmasecLtd_mojoScore_3794092.png",
        "date": "2026-01-19 10:10:03",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Genpharmasec Ltd Stock Hits 52-Week Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpharmasec-ltd-stock-hits-52-week-low-amid-continued-downtrend-3790016",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GenpharmasecLtd_priceRelatedfactors_3790016.png",
        "date": "2026-01-12 11:41:06",
        "description": "Genpharmasec Ltd’s shares declined to a fresh 52-week and all-time low of Rs.1.23 on 12 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its valuation and financial metrics."
      }
    ],
    "total": 5416,
    "sid": "329838",
    "stock_news_url": "https://www.marketsmojo.com/news/genpharmasec-329838"
  },
  "announcements": [
    {
      "caption": "Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 31St December 2025.",
      "datetime": "09-Feb-2026",
      "details": "Statement of deviation or variation in the use of proceeds of Rights issue for the Quarter ended 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Standalone & Consolidated Financial Result Of The Company For The Quarter Ended December 31 2025.",
      "datetime": "09-Feb-2026",
      "details": "Unaudited Standalone & Consolidated Financial Result of the company for the quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Monday February 09 2026.",
      "datetime": "09-Feb-2026",
      "details": "Outcome of the Meeting of Board of Directors held on Monday February 09 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Apr 19",
          "dt": "2019-04-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:1</strong> rights issue, ex-date: 09 Jan 24",
          "dt": "2024-01-09",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Are Genpharmasec Ltd latest results good or bad?

2026-02-10 19:23:08

Genpharmasec Ltd's latest financial results for Q3 FY26 reveal significant operational challenges despite a remarkable surge in revenue. The company reported net sales of ₹39.83 crores, reflecting a substantial year-on-year growth of 369.69%. This marks the highest quarterly revenue in its recent history. However, this revenue growth has not translated into profitability, as the company posted a net loss of ₹0.83 crores, which is a stark contrast to the previous year's profit. The operating margin has turned negative at -3.09%, a drastic decline from the positive margin of 8.37% achieved in the same quarter last year. This indicates a troubling disconnect between revenue generation and cost management. The operating loss before other income was recorded at ₹1.23 crores, highlighting severe operational inefficiencies. Additionally, employee costs surged significantly, outpacing revenue growth, which raises ...

Read full news article

Genpharmasec Ltd is Rated Strong Sell

2026-02-10 10:10:25

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 10 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Genpharmasec Q3 FY26: Losses Mount as Operating Margins Turn Negative Despite Revenue Surge

2026-02-09 20:31:33

Genpharmasec Limited, a micro-cap trading and distribution company with a market capitalisation of ₹64.00 crores, has reported deeply concerning results for Q3 FY26 (October-December 2025), posting a net loss of ₹0.83 crores despite achieving its highest-ever quarterly revenue. The stock, currently trading at ₹1.16, has plummeted 48.21% over the past year and trades 51.67% below its 52-week high of ₹2.40, reflecting mounting investor concerns about the company's profitability trajectory.

Read full news article

Are Genpharmasec Ltd latest results good or bad?

2026-02-09 19:15:05

Genpharmasec Ltd's latest financial results reveal a complex picture of growth and operational challenges. In Q2 FY26, the company reported a net profit of ₹1.22 crore, which reflects a significant year-on-year increase of 269.70%. However, this positive trend is overshadowed by a sequential decline in net profit, which saw a dramatic drop of over 500% compared to the previous quarter. Revenue for the same quarter reached ₹12.04 crore, marking an impressive year-on-year growth of 131.54%. Yet, this growth was not consistent, as revenue declined by 14.06% from ₹14.01 crore in Q1 FY26. This volatility raises concerns about the sustainability of the company's revenue streams. The operating margin, excluding other income, improved to 7.81% from 4.04% in the previous year, indicating some operational leverage. However, it remains below the 8.61% achieved in Q4 FY25, highlighting ongoing inconsistencies in ope...

Read full news article

Genpharmasec Ltd Falls to 52-Week Low Amidst Continued Underperformance

2026-02-01 10:45:02

Genpharmasec Ltd, a company operating in the Trading & Distributors sector, has reached a new 52-week low of Rs.0.98, marking a significant decline in its stock price. This fresh low reflects ongoing pressures on the stock, which has underperformed both its sector and the broader market over the past year.

Read full news article

Genpharmasec Ltd is Rated Strong Sell

2026-01-30 10:10:35

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Genpharmasec Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

2026-01-21 11:17:27

Genpharmasec Ltd’s share price declined to a fresh 52-week low of Rs.1.06 today, marking a significant milestone in its ongoing downward trajectory. This new low reflects persistent pressures on the stock amid broader market weakness and company-specific factors.

Read full news article

Genpharmasec Ltd is Rated Strong Sell

2026-01-19 10:10:03

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Genpharmasec Ltd Stock Hits 52-Week Low Amid Continued Downtrend

2026-01-12 11:41:06

Genpharmasec Ltd’s shares declined to a fresh 52-week and all-time low of Rs.1.23 on 12 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its valuation and financial metrics.

Read full news article

View All News